IIR Globe IIR Data IIR
social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon

You are Trying to View a Premium Article

Pharma Merger Mania Continues: Thermo Fisher Offers $7.2 Billion for Patheon

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 231 Words

SUGAR LAND--May 17, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical-Biotech Industry merger and acquisition mania continues with Thermo Fisher Scientific's (NYSE:TMO) (Waltham, Massachusetts) $7.2 billion offer to acquire Patheon N.V (NYSE:PTHN) (Amsterdam, The Netherlands), a leading contract development and manufacturing organization (CDMO).

Within this article: Details on how the acquisition could change the landscape for pharmaceuticals.


Login or Register for Instant Access

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type:

Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter